1999
DOI: 10.1016/s0140-6736(99)07026-9
|View full text |Cite
|
Sign up to set email alerts
|

Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol efflux

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

4
171
1
2

Year Published

2000
2000
2015
2015

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 343 publications
(178 citation statements)
references
References 31 publications
4
171
1
2
Order By: Relevance
“…In macrophages, the LXRs regulate the expression of the adenosine triphosphate-binding cassette (ABC) proteins A1 and G1 (18 -22), which serve as free-cholesterol and phospholipid translocators enabling cholesterol efflux from the macrophage onto various acceptors, including nascent, cholesterol-poor HDL (18,21,(23)(24)(25)(26). Defective ABCA1 expression in humans is the basis for Tangier disease and is associated with cholesterol accumulation in peripheral tissues along with a near-total lack of cellular cholesterol efflux and plasma HDL (27)(28)(29)(30)(31). LXR-dependent regulation of cholesterol efflux may prove to be an important antiatherogenic process amenable to pharmacological intervention with LXR agonists.…”
Section: From Glaxosmithkline Research and Development Research Triamentioning
confidence: 99%
“…In macrophages, the LXRs regulate the expression of the adenosine triphosphate-binding cassette (ABC) proteins A1 and G1 (18 -22), which serve as free-cholesterol and phospholipid translocators enabling cholesterol efflux from the macrophage onto various acceptors, including nascent, cholesterol-poor HDL (18,21,(23)(24)(25)(26). Defective ABCA1 expression in humans is the basis for Tangier disease and is associated with cholesterol accumulation in peripheral tissues along with a near-total lack of cellular cholesterol efflux and plasma HDL (27)(28)(29)(30)(31). LXR-dependent regulation of cholesterol efflux may prove to be an important antiatherogenic process amenable to pharmacological intervention with LXR agonists.…”
Section: From Glaxosmithkline Research and Development Research Triamentioning
confidence: 99%
“…Individuals heterozygous for ABCA1 transporter mutations have diminished UC efflux to apo A-I from their fibroblasts in cell culture, low plasma HDL-cholesterol, and premature CHD (18,24 ). These findings have established that inefficient RCT by HDLs is a causal factor in atherogenesis in such individuals.…”
mentioning
confidence: 97%
“…Efflux of UC from cells to pre-␤ 0 -HDLs in tissue fluids exceeds its esterification, leading to accumulation of UC-rich discoidal HDLs in lymph (16,17 ). For this pathway of RCT, which presumably applies to arterial smooth muscle and macrophages, ABCA1 transporter function (4,18,19 ) and pre-␤-HDL concentration (20,21 ) appear to play critical roles in regulating UC efflux.…”
mentioning
confidence: 99%
“…ABCA1 has been shown to regulate the apolipoprotein-(apo) mediated lipid removal pathway from cells, 6 and both TD patients and mice with a disrupted Abca1 gene have defective transport of lipids from the Golgi to the plasma membrane. 7 Furthermore, mutations in ABCA1 have been found in some patients with familial hypoalphalipoproteinemia (FHA), 8 a relatively more common disorder than TD. Cellular cholesterol efflux appears to be abnormal in some patients with FHA due to mutant ABCA1, but there is no obvious tissue deposition of cholesterol esters, and the low plasma HDL cholesterol concentrations demonstrate an apparent autosomal codominant pattern of expression in ABCA1 mutation carriers.…”
mentioning
confidence: 99%